TABLE 3.

Percentages of clinical and microbiological success by MIC for ceftaroline fosamil-treated patients against S. aureus in the ME population for the pooled phase 3 ABSSSI studies

Ceftaroline MIC (mg/liter)	N	Clinical success, n/N (%)	Microbiological success (eradicated/presumed eradicated), n/N (%)
0.06	3	3/3 (100)	3/3 (100)
0.12	79	72/79 (91.1)	73/79 (92.4)
0.25	156	148/156 (94.9)	149/156 (95.5)
0.5	109	102/109 (93.6)	102/109 (93.6)
1	11	11/11 (100)	11/11 (100)
2	4	2/4 (50)	2/4 (50)
Total	362	338/362 (93.4)	340/362 (93.9)